Yiting Geng

1.9k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Yiting Geng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yiting Geng has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Yiting Geng's work include Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (8 papers) and MicroRNA in disease regulation (7 papers). Yiting Geng is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (8 papers) and MicroRNA in disease regulation (7 papers). Yiting Geng collaborates with scholars based in China and Taiwan. Yiting Geng's co-authors include Jingting Jiang, Changping Wu, Changping Wu, Changping Wu, Danxia Zhu, Xiao Zheng, Yanjie Xu, Qi Wang, Wenting He and Yingjie Shao and has published in prestigious journals such as Scientific Reports, Journal of Hematology & Oncology and Oncotarget.

In The Last Decade

Yiting Geng

31 papers receiving 1.4k citations

Hit Papers

N‐acetyltransferase 10 promotes colon cancer progression ... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiting Geng China 19 664 612 548 336 234 32 1.5k
Tanja Langsenlehner Austria 19 595 0.9× 325 0.5× 363 0.7× 322 1.0× 98 0.4× 56 1.2k
Naoki Hama Japan 22 729 1.1× 463 0.8× 442 0.8× 276 0.8× 164 0.7× 103 1.7k
Kaiming Wu China 18 509 0.8× 564 0.9× 589 1.1× 175 0.5× 109 0.5× 37 1.3k
Akira Tomokuni Japan 22 570 0.9× 778 1.3× 745 1.4× 339 1.0× 111 0.5× 93 1.8k
Wenzhuo He China 19 878 1.3× 241 0.4× 325 0.6× 279 0.8× 250 1.1× 84 1.3k
Ji‐Youn Sung South Korea 21 478 0.7× 400 0.7× 221 0.4× 309 0.9× 170 0.7× 90 1.4k
Yu Zhu China 22 248 0.4× 438 0.7× 415 0.8× 268 0.8× 148 0.6× 82 1.3k
Soichiro Funaki Japan 22 616 0.9× 346 0.6× 212 0.4× 683 2.0× 192 0.8× 146 1.7k
Marine Lefèvre France 18 291 0.4× 314 0.5× 208 0.4× 424 1.3× 157 0.7× 67 1.1k
Yingjie Shao China 18 589 0.9× 286 0.5× 299 0.5× 254 0.8× 179 0.8× 42 1.0k

Countries citing papers authored by Yiting Geng

Since Specialization
Citations

This map shows the geographic impact of Yiting Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiting Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiting Geng more than expected).

Fields of papers citing papers by Yiting Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiting Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiting Geng. The network helps show where Yiting Geng may publish in the future.

Co-authorship network of co-authors of Yiting Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Yiting Geng. A scholar is included among the top collaborators of Yiting Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiting Geng. Yiting Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Geng, Yiting, Xiao Zheng, Dachuan Zhang, et al.. (2024). CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabolism alteration. Biology Direct. 19(1). 36–36. 14 indexed citations
3.
Xia, Wei, et al.. (2024). TRIM23 promotes 5-Fluorouracil resistance in colorectal cancer by upregulating GALNT4 expression. APOPTOSIS. 30(3-4). 751–767. 2 indexed citations
4.
Xia, Wei, Yiting Geng, & Wenwei Hu. (2023). Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer. Cancers. 15(23). 5641–5641. 9 indexed citations
5.
Zheng, Xiao, Qi Wang, You Zhou, et al.. (2022). N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Communications. 42(12). 1347–1366. 123 indexed citations breakdown →
6.
Wei, Shanshan, Wenwei Hu, Jun Feng, & Yiting Geng. (2022). Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy. Cell Communication and Signaling. 20(1). 150–150. 19 indexed citations
7.
Geng, Yiting, Jun Feng, Hao Huang, et al.. (2022). Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis. Annals of Translational Medicine. 10(21). 1170–1170. 24 indexed citations
8.
Chen, Yuan, Yiting Geng, Junchao Huang, et al.. (2021). CircNEIL3 promotes cervical cancer cell proliferation by adsorbing miR-137 and upregulating KLF12. Cancer Cell International. 21(1). 34–34. 18 indexed citations
9.
He, Wenting, Dachuan Zhang, Dong Li, et al.. (2020). Knockdown of Long Non-coding RNA LINC00200 Inhibits Gastric Cancer Progression by Regulating miR-143-3p/SERPINE1 Axis. Digestive Diseases and Sciences. 66(10). 3404–3414. 16 indexed citations
10.
Geng, Yiting, Jingting Jiang, & Changping Wu. (2018). Function and clinical significance of circRNAs in solid tumors. Journal of Hematology & Oncology. 11(1). 98–98. 207 indexed citations
11.
Geng, Yiting, Danxia Zhu, Chen Wu, et al.. (2018). A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. International Immunopharmacology. 65. 503–510. 127 indexed citations
12.
Shao, Yingjie, Yiting Geng, Wendong Gu, et al.. (2016). Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma. Journal of Thoracic Oncology. 11(10). 1774–1784. 54 indexed citations
13.
Geng, Yiting, Yingjie Shao, Danxia Zhu, et al.. (2016). Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis. Scientific Reports. 6(1). 39482–39482. 187 indexed citations
14.
Geng, Yiting, Yingjie Shao, Wenting He, et al.. (2015). Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis. Cellular Physiology and Biochemistry. 37(4). 1560–1571. 199 indexed citations
15.
Shao, Yingjie, Zhonghua Ning, Jun Chen, et al.. (2015). Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamouscell carcinoma undergoing radical esophagectomy. Scientific Reports. 5(1). 18811–18811. 42 indexed citations
16.
Shao, Yingjie, Yiting Geng, Wendong Gu, et al.. (2015). Prognostic Role of Tissue and Circulating MicroRNA-200c in Malignant Tumors: a Systematic Review and Meta-Analysis. Cellular Physiology and Biochemistry. 35(3). 1188–1200. 23 indexed citations
17.
Shao, Yingjie, Yiting Geng, Wendong Gu, et al.. (2014). Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: A meta-analysis. Biomedicine & Pharmacotherapy. 68(8). 969–977. 16 indexed citations
18.
Geng, Yiting, et al.. (2011). [Expression of HER-2 and leptin in gastric cancer and their clinical significance].. PubMed. 33(10). 764–9. 3 indexed citations
19.
Xu, Yanjie, Yongfeng Shao, Xia Zhao, et al.. (2011). Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis. Journal of Cancer Research and Clinical Oncology. 137(12). 1841–1848. 23 indexed citations
20.
Li, Xiaodong, Yiting Geng, Changping Wu, et al.. (2010). Restoration of Gefitinib Efficacy Following Chemotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer. Onkologie. 33(8-9). 466–469. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026